Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$24.40 USD

24.40
1,724,666

+0.96 (4.10%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $24.42 +0.02 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics

Zacks Equity Research

Encompass Health's (EHC) Expansion Plans Continue in Florida

by Zacks Equity Research

Encompass Health (EHC) continues to expand in Florida via hospitals in order to offer improved health services in the state.

Zacks Equity Research

Grab These Stocks With Momentum Anomaly for Better Returns

by Zacks Equity Research

These fast movers are currently witnessing a short-term pullback in price. So make sure you're making the most of this opportunity.

Sweta Killa headshot

Nasdaq Tops 11,000: 5 Best Stocks With Room for More Upside

by Sweta Killa

On Aug 6, the Nasdaq Composite Index topped the milestone of 11,000. The tech-heavy laden completed its 1000-point journey in 40 trading days, representing the fastest ever rise in 20 years.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Nautilus, Veritone, Quidel, DocuSign and Shopify

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Nautilus, Veritone, Quidel, DocuSign and Shopify

Sweta Killa headshot

5 Growth ETFs & Stocks to Ride the Market Rally

by Sweta Killa

Growth investing has taken the lead over value and is likely to stay given a slew of reasons.

Zacks Equity Research

The Zacks Analyst Blog Highlights: PulteGroup, Quidel, D.R. Horton and West Pharmaceutical Services

by Zacks Equity Research

The Zacks Analyst Blog Highlights: PulteGroup, Quidel, D.R. Horton and West Pharmaceutical Services

Zacks Equity Research

Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Nalak Das headshot

Wall Street is Northbound Defying All Concerns: 5 Top Picks

by Nalak Das

A new bull market that was developed last quarter exiting the coronavirus-induced short bear market, is raging forward in the third quarter too.

Zacks Equity Research

Quidel (QDEL) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Quidel (QDEL) delivered earnings and revenue surprises of 66.07% and 0.18%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products Stock Earnings on Jul 30: BAX, SYK & More

by Trina Mukherjee

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

Zacks Equity Research

Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FNY

Zacks Equity Research

Should iShares Morningstar SmallCap Growth ETF (JKK) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for JKK

Zacks Equity Research

Quidel (QDEL) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $255.51 in the latest trading session, marking a -0.67% move from the prior day.

Zacks Equity Research

Quidel (QDEL) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Quidel (QDEL) is likely to have witnessed an uptick in rapid immunoassay revenues in Q2.

Zacks Equity Research

Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Quidel (QDEL) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Quidel (QDEL) closed at $242.73, marking a -1.4% move from the previous day.

Zacks Equity Research

Quidel (QDEL) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $246.64 in the latest trading session, marking a +0.69% move from the prior day.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Quidel (QDEL)

by Zacks Equity Research

Quidel (QDEL) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

AdaptHealth (AHCO) Catches Eye: Stock Jumps 6.5%

by Zacks Equity Research

AdaptHealth (AHCO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Quidel (QDEL) Catches Eye: Stock Jumps 6.3%

by Zacks Equity Research

Quidel (QDEL) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Sreoshi Bera headshot

5 Stocks to Fight Volatility Stemming From the Coronavirus Spike

by Sreoshi Bera

Investing in stocks from defensive sectors like utilities, healthcare and consumer staples and remote working can prove prudent in the current market scenario.

Zacks Equity Research

Quidel, Keysight Technologies, Adobe, Nvidia and Zoom Video as Zacks Bull and Bear of the Day

by Zacks Equity Research

Quidel, Keysight Technologies, Adobe, Nvidia and Zoom Video as Zacks Bull and Bear of the Day

Kevin Cook headshot

Bull of the Day: Quidel (QDEL)

by Kevin Cook

Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply